Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
50.10
Dollar change
+0.72
Percentage change
1.46
%
IndexS&P 500 P/E12.71 EPS (ttm)3.94 Insider Own0.07% Shs Outstand2.10B Perf Week0.68%
Market Cap101.94B Forward P/E6.82 EPS next Y7.34 Insider Trans-0.50% Shs Float2.03B Perf Month-2.30%
Income8.29B PEG- EPS next Q1.76 Inst Own78.76% Short Float / Ratio1.32% / 2.08 Perf Quarter-19.22%
Sales44.94B P/S2.27 EPS this Y-2.05% Inst Trans-0.74% Short Interest26.80M Perf Half Y-23.70%
Book/sh14.25 P/B3.52 EPS next Y-2.63% ROA8.75% Target Price64.05 Perf Year-37.59%
Cash/sh3.80 P/C13.17 EPS next 5Y-0.25% ROE26.87% 52W Range48.25 - 81.43 Perf YTD-30.37%
Dividend2.25 P/FCF8.72 EPS past 5Y37.06% ROI13.22% 52W High-38.48% Beta0.33
Dividend %4.49% Quick Ratio1.07 Sales past 5Y19.14% Gross Margin58.24% 52W Low3.83% ATR1.08
Employees34300 Current Ratio1.18 Sales Q/Q-2.25% Oper. Margin20.10% RSI (14)43.19 Volatility1.84% 2.07%
OptionableYes Debt/Eq1.35 EPS Q/Q24.93% Profit Margin18.44% Rel Volume0.99 Prev Close49.38
ShortableYes LT Debt/Eq1.16 EarningsOct 26 BMO Payout74.28% Avg Volume12.90M Price50.10
Recom2.48 SMA20-0.69% SMA50-7.12% SMA200-19.83% Volume12,729,694 Change1.46%
Date Action Analyst Rating Change Price Target Change
Nov-15-23Downgrade Cantor Fitzgerald Overweight → Neutral $68 → $55
Nov-09-23Initiated Deutsche Bank Hold $55
Nov-02-23Downgrade Daiwa Securities Outperform → Neutral $68 → $54
Oct-27-23Upgrade HSBC Securities Reduce → Hold $55 → $53
Oct-27-23Downgrade William Blair Outperform → Mkt Perform
Oct-27-23Downgrade BMO Capital Markets Outperform → Market Perform $60
Oct-20-23Resumed UBS Neutral $70 → $60
Jul-14-23Initiated HSBC Securities Reduce $56
Jul-10-23Initiated SVB Securities Market Perform $66
Jun-28-23Initiated Daiwa Securities Outperform $70
Dec-01-23 01:56PM
07:05AM
03:00AM
Nov-30-23 08:02AM
Nov-28-23 02:51PM
10:02AM Loading…
10:02AM
07:01AM
06:30AM
Nov-26-23 06:51AM
Nov-24-23 05:30AM
Nov-23-23 04:47PM
Nov-22-23 04:01PM
09:09AM
05:04AM
Nov-21-23 10:15AM
04:55PM Loading…
Nov-20-23 04:55PM
04:48PM
03:16PM
02:56PM
01:25PM
12:32PM
12:17PM
12:02PM
11:58AM
11:58AM
11:47AM
11:03AM
10:38AM
10:08AM
09:42AM
08:51AM Loading…
08:51AM
08:30AM
07:18AM
06:59AM
06:52AM
Nov-19-23 08:15AM
Nov-17-23 10:45AM
Nov-16-23 11:17AM
07:08AM
05:59AM
Nov-15-23 07:20PM
05:06PM
05:01PM
03:04AM
Nov-14-23 10:01AM
08:45AM
07:14AM
Nov-13-23 02:00PM
06:30AM
Nov-11-23 07:25AM
Nov-09-23 04:18PM
10:14AM
08:45AM
03:47AM
Nov-08-23 09:50AM
05:21AM
Nov-06-23 09:02AM
07:54AM
07:41AM
07:12AM
06:59AM
02:00AM
Nov-02-23 07:03PM
11:34AM
06:59AM
Oct-31-23 06:25PM
03:49AM
Oct-30-23 08:19PM
04:35PM
03:42PM
11:08AM
09:50AM
08:00AM
06:59AM
06:18AM
05:46AM
05:24AM
Oct-28-23 03:23PM
Oct-27-23 10:01AM
08:32AM
07:15AM
Oct-26-23 11:43PM
05:58PM
04:50PM
04:03PM
03:30PM
02:00PM
12:13PM
12:13PM
12:09PM
11:28AM
10:54AM
10:25AM
09:50AM
09:30AM
09:22AM
09:04AM
08:15AM
07:45AM
07:43AM
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BOERNER CHRISTOPHER S.Chief Executive OfficerNov 28Buy48.863,071150,04979,384Nov 30 06:32 PM
Samuels Theodore R. IIDirectorNov 20Buy49.818,500423,38535,500Nov 21 07:01 PM
Powell AnnEVP, Chief Human ResourcesAug 24Sale61.2517,9861,101,64227,868Aug 28 05:28 PM
Plenge Robert MEVP, Chief Research OfficerAug 03Sale61.1473244,7546,584Aug 07 05:24 PM
Weese MichelleEVP, Corporate AffairsJul 01Option Exercise0.001,88504,135Jul 05 05:26 PM
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.Jul 01Option Exercise0.009,357052,032Jul 05 05:23 PM
Lenkowsky AdamEVP, Chief Commercial OfficerJun 03Option Exercise0.001,07701,077Jun 06 07:39 PM
VESSEY RUPERTEVP & President, ResearchMay 03Sale67.0650,3853,378,81847,751May 04 05:51 PM
Greenlees SharonSVP & ControllerMay 02Option Exercise0.001,0170728May 03 07:36 PM
Mily ElizabethEVP, Strategy & BDApr 01Option Exercise0.006,346035,873Apr 04 08:40 PM
Shanahan KarinEVP, Glob. Prod. Dev. & SupplyApr 01Option Exercise0.003,30604,918Apr 04 08:40 PM
Mily ElizabethEVP, Strategy & BDMar 10Option Exercise0.0029,636038,173Mar 14 08:40 PM
VESSEY RUPERTEVP & President, ResearchMar 10Option Exercise0.0066,9350118,263Mar 14 08:34 PM
LEUNG SANDRAEVP, General CounselMar 10Option Exercise0.0057,9900356,920Mar 14 08:28 PM
Powell AnnEVP, Chief Human ResourcesMar 10Option Exercise0.0034,447053,100Mar 14 08:18 PM
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.Mar 10Option Exercise0.0038,978054,035Mar 14 08:18 PM
Weese MichelleEVP, Corporate AffairsMar 10Option Exercise0.001,59002,793Mar 14 08:14 PM
Shanahan KarinEVP, Glob. Prod. Dev. & SupplyMar 10Option Exercise0.002,44702,447Mar 14 08:12 PM
Caforio GiovanniBoard Chair and CEOMar 10Option Exercise0.00234,6760431,381Mar 14 08:13 PM
Elkins David VEVP, Chief Financial OfficerMar 10Option Exercise0.0071,8710185,308Mar 14 08:13 PM
BOERNER CHRISTOPHER S.EVP, Chief Commercial OfficerMar 10Option Exercise0.0059,111091,880Mar 14 08:13 PM
Meyers Gregory ScottEVP, Chief Digital & Tech Off.Mar 10Option Exercise0.002,83604,648Mar 14 08:14 PM
Caforio GiovanniBoard Chair and CEOFeb 06Sale74.65240,00017,916,000236,104Feb 08 08:09 PM
Powell AnnEVP, Chief Human ResourcesFeb 06Sale74.6911,183835,25823,043Feb 08 08:09 PM
Meyers Gregory ScottEVP, Chief Digital & Tech Off.Feb 01Option Exercise0.002,54302,543Feb 03 07:18 PM